USITC Section 337 Institution (337-TA-1519), Certain Melanoma Predictive and Prognostic Tests

The U.S. International Trade Commission instituted a Section 337 investigation (337-TA-1519) on August 27, 2026, following a complaint filed by Castle Biosciences, Inc. on July 10, 2026. The complaint alleges unfair competition through false and misleading advertising related to the importation and sale of certain melanoma predictive and prognostic tests and components thereof. The complainant seeks a limited...